Comment
doi: 10.1016/S1470-2045(21)00583-0.
Radiotherapy with genomic-adjusted radiation dose
Affiliations
- PMID: 34735811
- DOI: 10.1016/S1470-2045(21)00583-0
Item in Clipboard
Comment
Radiotherapy with genomic-adjusted radiation dose
Lancet Oncol.
2021 Nov.
No abstract available
Conflict of interest statement
SB is a consultant for Elsevier's ClinicalPath and an employee of Varian Medical Systems, Palo Alto, CA, USA. All other authors declare no competing interests.
Comment in
-
Radiotherapy with genomic-adjusted radiation dose - Authors' reply.Lancet Oncol. 2021 Nov;22(11):e470-e471. doi: 10.1016/S1470-2045(21)00601-X. Lancet Oncol. 2021. PMID: 34735812 No abstract available.
Comment on
-
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.Lancet Oncol. 2021 Sep;22(9):1221-1229. doi: 10.1016/S1470-2045(21)00347-8. Epub 2021 Aug 4. Lancet Oncol. 2021. PMID: 34363761
-
Radiotherapy with genomic-adjusted radiation dose.Lancet Oncol. 2021 Nov;22(11):e468. doi: 10.1016/S1470-2045(21)00541-6. Lancet Oncol. 2021. PMID: 34735810 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
